Clarithromycin Extended-release
NDC Package 72763-100-06

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Clarithromycin Extended-release is a . Marketed by Estreno Pharmaceuticals, Llc, this product is identified by NDC 72763-100 and is authorized under FDA application ANDA203243.

Identification & Billing

NDC Package Code
72763-100-06
Package Description
1 BOTTLE in 1 CARTON / 60 TABLET, EXTENDED RELEASE in 1 BOTTLE
Product Code
72763-100
11-Digit Billing Format
72763010006

Clinical Specifications

Proprietary Name
Clarithromycin Extended-release
Dosage Form
-

Regulatory & Marketing

Labeler Name
Estreno Pharmaceuticals, Llc
FDA Application #
ANDA203243
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
01-01-2018
End Marketing Date
04-21-2020
Listing Expiration
04-21-2020
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 72763-100-06 identifies a specific commercial package of 1 bottle in 1 carton / 60 tablet, extended release in 1 bottle of Clarithromycin Extended-release, labeled by Estreno Pharmaceuticals, Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Estreno Pharmaceuticals, Llc on January 01, 2018. The current certification is valid through April 21, 2020.

How is this Estreno Pharmaceuticals, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 72763010006. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
72763-100-06
11-Digit CMS (5-4-2)
72763-0100-06

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.